Breast cancer risk - From genetics to molecular understanding of pathogenesis

Geburtshilfe und Frauenheilkunde

Volumn 73, Issue 12, 2013, Pages 1228-1235

  Fasching, P A ^a   Ekici, A B ^b   Wachter, D L ^b   Hein, A ^a   Bayer, C M ^a   Haberle L ^a   Loehberg, C R ^a   Schneider, M ^a   Jud, S M ^a   Heusinger, K ^a   Rubner M ^a   Rauh, C ^a   Bani, M R ^a   Lux, M P ^a   Schulz Wendtland, R ^b   Hartmann, A ^b   Beckmann, M W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

BRCA; breast cancer risk; gene environment interaction; genetic risk factors; prediction models

Indexed keywords

BRCA1 PROTEIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN MDMX; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER GENETICS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESEARCH; CANCER RISK; GENE MUTATION; GENETIC RISK; HETEROZYGOTE; HUMAN; MAMMOGRAPHY; MOLECULAR GENETICS; PATHOGENESIS; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER;

EID: 84896510788     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0033-1360178     Document Type: Article

References (71)

1. Melcher C., Scholz C., Jager B. et al. Breast cancer: state of the art and new findings. Geburtsh Frauenheilk: 2012; 72 215 224
2. Kolberg H. C., Luftner D., Lux M. P. et al. Breast cancer 2012 - new aspects. Geburtsh Frauenheilk: 2012; 72 602 615
3. Kummel S., Kolberg H. C., Luftner D. et al. Breast cancer 2011 - new aspects. Geburtsh Frauenheilk: 2011; 71 939 953
4. Schmidt M., Fasching P. A., Beckmann M. W. et al. Biomarkers in breast cancer - an update. Geburtsh Frauenheilk: 2012; 72 819 832
5. Miki Y., Swensen J., Shattuck-Eidens D. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science: 1994; 266 66 71 (Pubitemid 24345325)
6. Wooster R., Bignell G., Lancaster J. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature: 1995; 378 789 792 (Pubitemid 26004412)
7. Fasching P. A., Gayther S., Pearce L. et al. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol: 2009; 3 171 181
8. Michailidou K., Hall P., Gonzalez-Neira A. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet: 2013; 45 353 361
9. Bojesen S. E., Pooley K. A., Johnatty S. E. et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet: 2013; 45 371 384
10. Garcia-Closas M., Couch F. J., Lindstrom S. et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet: 2013; 45 392 398
11. Couch F. J., Wang X., McGuffog L. et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genetics: 2013; 9 e1003212
12. Kim Y., Kim J., Lee H. D. et al. Spectrum of EGFR gene copy number changes and KRAS gene mutation status in Korean triple negative breast cancer patients. PLoS One: 2013; 8 e79014
13. Smolarz B., Zadrozny M., Duda-Szymanska J. et al. RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol: 2013; 64 39 43
14. Stevens K. N., Vachon C. M., Couch F. J. Genetic susceptibility to triple-negative breast cancer. Cancer Res: 2013; 73 2025 2030
15. Haiman C. A., Chen G. K., Vachon C. M. et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet: 2011; 43 1210 1214
16. Stevens K. N., Fredericksen Z., Vachon C. M. et al. 19p13.1 is a triple negative-specific breast cancer susceptibility locus. Cancer Res: 2012; 72 1795 1803
17. Siddiq A., Couch F. J., Chen G. K. et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet: 2012; 21 5373 5384
18. Lambe M., Hsieh C., Trichopoulos D. et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med: 1994; 331 5 9 (Pubitemid 24195593)
19. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet: 2002; 360 187 195
20. Yang X. R., Chang-Claude J., Goode E. L. et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst: 2011; 103 250 263
21. Nickels S., Truong T., Hein R. et al. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genetics: 2013; 9 e1003284
22. Lanigan F., OEConnor D., Martin F. et al. Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci: 2007; 64 3159 3184
23. Milne R. L., Gaudet M. M., Spurdle A. B. et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res: 2010; 12 R110
24. McCormack V. A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev: 2006; 15 1159 1169
25. Heusinger K., Loehberg C. R., Haeberle L. et al. Mammographic density as a risk factor for breast cancer in a German case-control study. Eur J Cancer Prev: 2011; 20 1 8
26. Boyd N. F., Guo H., Martin L. J. et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med: 2007; 356 227 236 (Pubitemid 46143226)
27. Fasching P. A., Heusinger K., Loehberg C. R. et al. Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol: 2006; 60 398 404
28. Heusinger K., Jud S. M., Haberle L. et al. Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. Int J Cancer: 2012; 131 2643 2649
29. Heusinger K., Jud S. M., Haberle L. et al. Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer. Breast Cancer Res Treat: 2012; 135 885 892
30. DeFilippis R. A., Chang H., Dumont N. et al. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov: 2012; 2 826 839
31. Vachon C. M., Scott C. G., Fasching P. A. et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev: 2012; 21 1156 1166
32. Fasching P. A., Pharoah P. D., Cox A. et al. The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet: 2012; 21 3926 3939
33. Berry D. A., Iversen E. S. jr., Gudbjartsson D. F. et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol: 2002; 20 2701 2712 (Pubitemid 34575644)
34. Parmigiani G., Berry D., Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet: 1998; 62 145 158 (Pubitemid 28093844)
35. Parmigiani G. BRCAPRO. 2004; Online: http://astor.som.jhmi.edu/ BayesMendel/brcapro.html last access: 01.11.2011
36. Antoniou A. C., Cunningham A. P., Peto J. et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer: 2008; 98 1457 1466 (Pubitemid 351543573)
37. Antoniou A. C., Pharoah P. P., Smith P. et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer: 2004; 91 1580 1590 (Pubitemid 39486366)
38. Tyrer J., Duffy S. W., Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med: 2004; 23 1111 1130 (Pubitemid 38477070)
39. Antoniou A. BOADICEA. 2009; Online: http://www.srl.cam.ac.uk/genepi/ boadicea/boadicea-home.html last access: 01.11.2011
40. National Institutes of Health Breast Cancer Risk Assessment Tool. 2011; Online: http://www.cancer.gov/bcrisktool/ last access: 01.11.2011
41. Gail M. H., Benichou J. Validation studies on a model for breast cancer risk. J Natl Cancer Inst: 1994; 86 573 575
42. Claus E. B., Risch N., Thompson W. D. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat: 1993; 28 115 120 (Pubitemid 24056083)
43. Darabi H., Czene K., Zhao W. et al. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res: 2012; 14 R25
44. Tice J. A., Cummings S. R., Smith-Bindman R. et al. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med: 2008; 148 337 347 (Pubitemid 351665464)
45. Azzato E. M., Tyrer J., Fasching P. A. et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst: 2010; 102 650 662
46. Antoniou A. C., Wang X., Fredericksen Z. S. et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet: 2010; 42 885 892
47. Broeks A., Schmidt M. K., Sherman M. E. et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet: 2011; 20 3289 3303
48. Stevens K. N., Vachon C. M., Lee A. M. et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res: 2011; 71 6240 6249
49. Milne R. L., Benitez J., Nevanlinna H. et al. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst: 2009; 101 1012 1018
50. Fasching P. A., Ekici A. B., Adamietz B. R. et al. Breast cancer risk - genes, environment and clinics. Geburtsh Frauenheilk: 2011; 71 1056 1066
51. Thomas G., Jacobs K. B., Kraft P. et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet: 2009; 41 579 584
52. Stacey S. N., Manolescu A., Sulem P. et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet: 2007; 39 865 869 (Pubitemid 47014497)
53. Cox A., Dunning A. M., Garcia-Closas M. et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet: 2007; 39 352 358 (Pubitemid 46328496)
54. Ahmed S., Thomas G., Ghoussaini M. et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet: 2009; 41 585 590
55. Stacey S. N., Manolescu A., Sulem P. et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet: 2008; 40 703 706 (Pubitemid 351748861)
56. Easton D. F., Pooley K. A., Dunning A. M. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature: 2007; 447 1087 1093 (Pubitemid 47014426)
57. Zheng W., Long J., Gao Y. T. et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet: 2009; 41 324 328
58. Turnbull C., Ahmed S., Morrison J. et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet: 2010; 42 504 507
59. Fletcher O., Johnson N., Orr N. et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst: 2011; 103 425 435
60. French J. D., Ghoussaini M., Edwards S. L. et al. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet: 2013; 92 489 503
61. Ghoussaini M., Fletcher O., Michailidou K. et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet: 2012; 44 312 318
62. Milne R. L., Antoniou A. C. Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. Ann Oncol: 2011; 22 01 i11 i17
63. Antoniou A. C., Sinilnikova O. M., Simard J. et al. RAD51 135G - >C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet: 2007; 81 1186 1200 (Pubitemid 350211449)
64. Engel C., Versmold B., Wappenschmidt B. et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev: 2010; 19 2859 2868
65. Antoniou A. C., Spurdle A. B., Sinilnikova O. M. et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet: 2008; 82 937 948
66. Antoniou A. C., Sinilnikova O. M., McGuffog L. et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet: 2009; 18 4442 4456
67. Antoniou A. C., Kartsonaki C., Sinilnikova O. M. et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet: 2011; 20 3304 3321
68. Ou J., Wu T., Sijmons R. et al. Prevalence of BRCA1 and BRCA2 germline mutations in breast cancer women of multiple ethnic region in northwest China. J Breast Cancer: 2013; 16 50 54
69. Hartman A. R., Kaldate R. R., Sailer L. M. et al. Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer: 2012; 118 2787 2795
70. Gonzalez-Angulo A. M., Timms K. M., Liu S. et al. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res: 2011; 17 1082 1089
71. Lips E. H., Mulder L., Oonk A. et al. Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers. Br J Cancer: 2013; 108 2172 2177